Clarence Takashi Sasaki, MD, FACS

Charles W. Ohse Professor of Surgery (Otolaryngology)

Clinical Interests

  • Head and Neck Neoplasms
  • Laryngeal Diseases
  • Otorhinolaryngologic Diseases
  • Otorhinolaryngologic Neoplasms
  • Pharyngeal Diseases

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Surgery: Otolaryngology Surgery: Head & Neck Cancer Surgery Program

Yale Cancer Center: Head & Neck Cancers Program

Yale Medicine

Office of Cooperative Research

Clinical Trials

Conditions Study Title
Larynx, Lip, Oral Cavity and Pharynx A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Soft Tissue Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Larynx, Lip, Oral Cavity and Pharynx Single-Arm Phase II Trial of Dual Inhibition of EGFR With Afatinib and Cetuximab With Correlative Studies in the Second-Line Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck
Larynx, Lip, Oral Cavity and Pharynx, Ill-Defined Sites A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
Lip, Oral Cavity and Pharynx Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Edit this profile